Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1978-5-17
pubmed:abstractText
A guinea pig subcutaneous chamber model was used to evaluate the specificity of the immune response resulting from Neisseria meningitidis infection. Small numbers of meningococci easily infected the chambers. The infections persisted for 6-8 days with relatively high levels of organisms (10(5)-10(6)/milliliter) in the chambers, and were then rapidly eliminated and no organisms could be cultured beyond day 14. Clearance of infection correlated with appearance of circulating antibody. Antibody against both the protein serotype antigen and the capsular polysaccharide were induced as a result of meningococcal infection. The group-specific polysaccharide response peaked 2-3 wk after the animals were inoculated, while the type-specific protein response peaked at 5-6 wk. The animals were quite resistant to reinfection with either the homologous serogroup or serotype.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/416163-16558086, http://linkedlifedata.com/resource/pubmed/commentcorrection/416163-16558113, http://linkedlifedata.com/resource/pubmed/commentcorrection/416163-19870925, http://linkedlifedata.com/resource/pubmed/commentcorrection/416163-403994, http://linkedlifedata.com/resource/pubmed/commentcorrection/416163-4113792, http://linkedlifedata.com/resource/pubmed/commentcorrection/416163-416164, http://linkedlifedata.com/resource/pubmed/commentcorrection/416163-4206246, http://linkedlifedata.com/resource/pubmed/commentcorrection/416163-4329898, http://linkedlifedata.com/resource/pubmed/commentcorrection/416163-4631911, http://linkedlifedata.com/resource/pubmed/commentcorrection/416163-4632041, http://linkedlifedata.com/resource/pubmed/commentcorrection/416163-4632471, http://linkedlifedata.com/resource/pubmed/commentcorrection/416163-4947187, http://linkedlifedata.com/resource/pubmed/commentcorrection/416163-4977281, http://linkedlifedata.com/resource/pubmed/commentcorrection/416163-4979390, http://linkedlifedata.com/resource/pubmed/commentcorrection/416163-5001751, http://linkedlifedata.com/resource/pubmed/commentcorrection/416163-5005401, http://linkedlifedata.com/resource/pubmed/commentcorrection/416163-60332, http://linkedlifedata.com/resource/pubmed/commentcorrection/416163-62821, http://linkedlifedata.com/resource/pubmed/commentcorrection/416163-805852, http://linkedlifedata.com/resource/pubmed/commentcorrection/416163-806688, http://linkedlifedata.com/resource/pubmed/commentcorrection/416163-812949, http://linkedlifedata.com/resource/pubmed/commentcorrection/416163-819118, http://linkedlifedata.com/resource/pubmed/commentcorrection/416163-819642, http://linkedlifedata.com/resource/pubmed/commentcorrection/416163-820636, http://linkedlifedata.com/resource/pubmed/commentcorrection/416163-821971, http://linkedlifedata.com/resource/pubmed/commentcorrection/416163-822114, http://linkedlifedata.com/resource/pubmed/commentcorrection/416163-826482
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0022-1007
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
147
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
619-28
pubmed:dateRevised
2010-9-2
pubmed:meshHeading
pubmed:year
1978
pubmed:articleTitle
Protection against group B meningococcal disease. II. Infection and resulting immunity in a guinea pig model.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, U.S. Gov't, Non-P.H.S.